In addition, oral administration of inactivated Akk or the outer membrane protein of Akk (Amuc_1100) can also regulate CD8+ T cells, improving IBD and preventing the occurrence of CACC (Wang et al., 2020b). Here, CD8A is linked to irritable bowel syndrome.